Due to Regulation (EU) 2022/1644, it is required for the first time to monitor veterinary drug residues of coccidiostats and antiparasitics (groups A3d, B2), non-steroidal anti-inflammatory drugs (NSAIDs), sedatives (groups A2d, A3f), and other substances (group B1e) in eggs.This work contains the first method addressing the simultaneous determination of 22 pharmacol. active substances of those families in hen eggs, following the requirements of Regulation (EU) 2021/808, recently amended by Regulation (EU) 2024/2052.Sample preparation was based on a liquid extraction (with acetonitrile and Na2SO4) followed by solid phase extraction, as a cleanup step, and anal. by UHPLC-MS/MS.After method development, the anal. figures of merit were evaluated, observing satisfactory relative matrix effects (≤ 20 %), linearity (R2 ≥ 0.98), accuracy (85-113 %), trueness (-15 to +13 %), repeatability (2.5-18.2 %), reproducibility (3.5-23.1 %), specificity (blank signals <30 % of limit of quantification), and ruggedness (78-130 %).The method limits of quantification values ranged from 0.5 to 30 μg kg-1, with decision limit for confirmation (CCα) values from 0.57 to 335.26 μg kg-1.